Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

A COMPARATIVE STUDY OF ORGAN DOSES ASSESSMENT FOR PATIENTS UNDERGOING CONVENTIONAL X-RAY EXAMINATIONS: PHANTOM EXPERIMENTS VS. CALCULATIONS.

Golikov V, Barkovsky A, Wallstrom E, Cederblad Å.

Radiat Prot Dosimetry. 2017 Aug 10:1-12. doi: 10.1093/rpd/ncx102. [Epub ahead of print]

PMID:
28981902
2.

Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study.

Kappos L, Li DK, Stüve O, Hartung HP, Freedman MS, Hemmer B, Rieckmann P, Montalban X, Ziemssen T, Hunter B, Arnould S, Wallström E, Selmaj K.

JAMA Neurol. 2016 Sep 1;73(9):1089-98. doi: 10.1001/jamaneurol.2016.1451.

PMID:
27380540
3.

Diagnosis of asthma in primary health care: a pilot study.

Ringsberg KC, Bjärneman P, Larsson R, Wallström E, Löwhagen O.

J Allergy (Cairo). 2014;2014:898965. doi: 10.1155/2014/898965. Epub 2014 Apr 10.

4.

Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study.

Selmaj K, Li DK, Hartung HP, Hemmer B, Kappos L, Freedman MS, Stüve O, Rieckmann P, Montalban X, Ziemssen T, Auberson LZ, Pohlmann H, Mercier F, Dahlke F, Wallström E.

Lancet Neurol. 2013 Aug;12(8):756-67. doi: 10.1016/S1474-4422(13)70102-9. Epub 2013 Jun 11. Erratum in: Lancet Neurol. 2013 Sep;12(9):846.

PMID:
23764350
5.

The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate.

Gergely P, Nuesslein-Hildesheim B, Guerini D, Brinkmann V, Traebert M, Bruns C, Pan S, Gray NS, Hinterding K, Cooke NG, Groenewegen A, Vitaliti A, Sing T, Luttringer O, Yang J, Gardin A, Wang N, Crumb WJ Jr, Saltzman M, Rosenberg M, Wallström E.

Br J Pharmacol. 2012 Nov;167(5):1035-47. doi: 10.1111/j.1476-5381.2012.02061.x.

6.

A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS.

Freedman MS, Bar-Or A, Oger J, Traboulsee A, Patry D, Young C, Olsson T, Li D, Hartung HP, Krantz M, Ferenczi L, Verco T; MAESTRO-01 Investigators.

Neurology. 2011 Oct 18;77(16):1551-60. doi: 10.1212/WNL.0b013e318233b240. Epub 2011 Oct 5.

PMID:
21975206
7.

Cerebrospinal fluid levels of a proliferation-inducing ligand (APRIL) are increased in patients with neuropsychiatric systemic lupus erythematosus.

Hopia L, Thangarajh M, Khademi M, Laveskog A, Wallström E, Svenungsson E, Andersson M.

Scand J Rheumatol. 2011;40(5):363-72. doi: 10.3109/03009742.2010.550900. Epub 2011 May 18.

PMID:
21585290
8.

RGMA and IL21R show association with experimental inflammation and multiple sclerosis.

Nohra R, Beyeen AD, Guo JP, Khademi M, Sundqvist E, Hedreul MT, Sellebjerg F, Smestad C, Oturai AB, Harbo HF, Wallström E, Hillert J, Alfredsson L, Kockum I, Jagodic M, Lorentzen J, Olsson T.

Genes Immun. 2010 Jun;11(4):279-93. doi: 10.1038/gene.2009.111. Epub 2010 Jan 14.

PMID:
20072140
9.

Gene expression profiling in multiple sclerosis: a disease of the central nervous system, but with relapses triggered in the periphery?

Brynedal B, Khademi M, Wallström E, Hillert J, Olsson T, Duvefelt K.

Neurobiol Dis. 2010 Mar;37(3):613-21. doi: 10.1016/j.nbd.2009.11.014. Epub 2009 Nov 26.

PMID:
19944761
10.

Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA.

Iacobaeus E, Ryschkewitsch C, Gravell M, Khademi M, Wallstrom E, Olsson T, Brundin L, Major E.

Mult Scler. 2009 Jan;15(1):28-35. doi: 10.1177/1352458508096870. Epub 2008 Sep 19.

11.

Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis.

Andersson A, Covacu R, Sunnemark D, Danilov AI, Dal Bianco A, Khademi M, Wallström E, Lobell A, Brundin L, Lassmann H, Harris RA.

J Leukoc Biol. 2008 Nov;84(5):1248-55. doi: 10.1189/jlb.1207844. Epub 2008 Jul 21.

PMID:
18644848
12.

Vra4 congenic rats with allelic differences in the class II transactivator gene display altered susceptibility to experimental autoimmune encephalomyelitis.

Harnesk K, Swanberg M, Ockinger J, Diez M, Lidman O, Wallström E, Lobell A, Olsson T, Piehl F.

J Immunol. 2008 Mar 1;180(5):3289-96.

13.

Induction of systemic TNFalpha in natalizumab-treated multiple sclerosis.

Khademi M, Stol D, Olsson T, Wallström E.

Eur J Neurol. 2008 Mar;15(3):309-12. doi: 10.1111/j.1468-1331.2007.02037.x. Epub 2008 Jan 9.

PMID:
18190511
14.

Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis.

Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallström E, Khademi M, Oturai A, Ryder LP, Saarela J, Harbo HF, Celius EG, Salter H, Olsson T, Hillert J.

Nat Genet. 2007 Sep;39(9):1108-13. Epub 2007 Jul 29.

PMID:
17660816
15.

Evaluation of conversion coefficients from measurable to risk quantities for external exposure over contaminated soil by use of physical human phantoms.

Golikov V, Wallström E, Wöhni T, Tanaka K, Endo S, Hoshi M.

Radiat Environ Biophys. 2007 Nov;46(4):375-82. Epub 2007 Jul 21.

PMID:
17643259
16.

Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.

Eltayeb S, Berg AL, Lassmann H, Wallström E, Nilsson M, Olsson T, Ericsson-Dahlstrand A, Sunnemark D.

J Neuroinflammation. 2007 May 7;4:14.

17.

Genetics of autoimmune neuroinflammation.

Olsson T, Jagodic M, Piehl F, Wallström E.

Curr Opin Immunol. 2006 Dec;18(6):643-9. Epub 2006 Sep 14. Review.

PMID:
16973343
18.

Advanced intercross line mapping of Eae5 reveals Ncf-1 and CLDN4 as candidate genes for experimental autoimmune encephalomyelitis.

Becanovic K, Jagodic M, Sheng JR, Dahlman I, Aboul-Enein F, Wallstrom E, Olofsson P, Holmdahl R, Lassmann H, Olsson T.

J Immunol. 2006 May 15;176(10):6055-64.

19.

No signs of immunoactivation in the cerebrospinal fluid during treatment with infliximab.

Andersson M, Svenungsson E, Khademi M, Lampa J, Brundin L, Wallström E.

Ann Rheum Dis. 2006 Sep;65(9):1237-40. Epub 2006 Apr 10.

20.

External and internal irradiation of a rural Bryansk (Russia) population from 1990 to 2000, following high deposition of radioactive caesium from the Chernobyl accident.

Thornberg C, Vesanen R, Wallström E, Zvonova I, Jesko T, Balonov M, Mattsson S.

Radiat Environ Biophys. 2005 Oct;44(2):97-106. Epub 2005 Nov 2.

PMID:
16175396

Supplemental Content

Loading ...
Support Center